Comprehensive Guide to Vonjo Patient Assistance

Shannon E. Epling MSc, Pharmaceutical Sciences Date: 06/15/2024

Skip the reading:

Vonjo® Patient Assistance Programs at PrescriberPoint

A 2021 survey revealed that pharmaceutical companies in the U.S. dedicate over five billion dollars each year to financial assistance and patient support programs. Despite this significant investment, only about 3% of patients take advantage of these resources. The primary reason appears to be a lack of awareness, with more than 72% of patients reporting they are not well-informed about these support options.

PrescriberPoint provides healthcare providers like yourself with access to a comprehensive suite of patient assistance and education resources. Our primary goal is to enhance the accessibility of these programs, thereby promoting patient awareness and fostering medication adherence. 

In this article, we will provide you with a digital map to uncover the support programs for Vonjo® (pacritinib), an anti-cancer medication used to treat myelofibrosis, which include patient savings programs, patient education, and prior authorization support.

Here are some of the resources available to you:

Patient Savings Programs:

PrescriberPoint provides access to financial assistance programs aimed at reducing out-of-pocket costs associated with Vonjo® for eligible patients. As a healthcare provider, you can access information about these programs and refer your patients to help alleviate financial obstacles that may impede medication adherence.

The CTI Access Program

Patients prescribed Vonjo have access to financial assistance programs, including the CTI Access patient support program. The CTI Access Program is a resource provided by CTI BioPharma, the pharmaceutical company behind Vonjo®.  The CTI Access program caters to patients with commercial or private insurance and, additionally, offers alternative assistance for patients with all insurance types. PrescriberPoint can provide enrollment forms, allowing patients to unlock savings while taking Vonjo®.

Co-pay Assistance

The CTI Access Program is available to provide financial support to eligible patients who are prescribed Vonjo®. Through the program, eligible patients gain access to various financial assistance options aimed at reducing the financial burden associated with Vonjo®. These options may include co-pay assistance, which helps reduce out-of-pocket costs for Vonjo prescriptions. By offering financial support towards co-pays, the program aims to make Vonjo more affordable and accessible for patients. To enroll in the CTI Access Program and check your patient’s eligibility for co-pay assistance, view eligibility criteria here

The program also provides resources to help patients navigate insurance coverage, so they can access the medication they need without facing excessive financial burdens. 

Treatment Delay and Disruption Solutions

CTI Access also offers two treatment delay and disruption solutions; Bridge Program and Patient Assistance Program (PAP):

Bridge Program

Provides up to 60 days of free drug to patients who meet the criteria below.

  • Documented therapy initiation delay or continuation ≥5 business days due to insurance coverage issues
  • Resident of US or Puerto Rico
  • Prescribed VONJO for an FDA-approved indication or a clinical compendia-recognized use
  • A completed Support Request Form must be on file with CTI Access®

Patient Assistance Program (PAP)

Provides free drug to patients without affordable access and who meet at least one of the criteria below.

At least one of the following:

  • No prescription insurance
  • No coverage for VONJO
  • The co-pay for VONJO is unaffordable, and the patient does not qualify for other options

AND all of the following:

  • Resident of US or Puerto Rico
  • Prescribed VONJO for an FDA-approved indication or a clinical compendia-recognized use
  • A completed Support Request Form and PAP application must be on file at CTI Access®
  • A PAP application will be made available after we prequalify the patient
  • Income restrictions as defined by CTI BioPharma Corp.

To check a patient’s availability for the CTI Access program, click here.

Patient Education

At PrescriberPoint, we offer an extensive range of patient-centered educational resources, aimed at enhancing patient’s knowledge and comprehension of their condition and the role of Vonjo® in its management. Materials provided by PrescriberPoint include external links to instructions for use, doctor’s discussion guides, and more.

As a healthcare provider, you can leverage these resources to educate your patients about their treatment options. These resources cover essential topics such as proper administration techniques for Vonjo®, effective management of potential side effects, and strategies for maintaining overall health while undergoing treatment. By utilizing these educational materials, you can provide your patients with the information they need to make informed decisions and actively participate in their own care journey. Click here to unlock patient education resources.

Prior Authorization Support

PrescriberPoint understands the challenges healthcare providers face when navigating the prior authorization process. That's why we offer comprehensive assistance to streamline this often complex and time-consuming procedure. By utilizing our prior authorization support services, you can optimize the process, reducing administrative burdens and ensuring your patients have timely access to the medication they require, such as Vonjo®. To facilitate this process further, we provide easy access to Prior Authorization documents for the most commonly encountered insurances. By clicking here, you can swiftly access the necessary forms and documentation, saving you valuable time and ensuring a smoother authorization process for your patients.


Get the latest insights delivered to your inbox

Explore our blog

Need Support? Get in touch